ARCHIVES

Scope Of Panel’s Inquiry Outlined In Letter To Members

This article is from The Cancer Letter archive.

Vol. 20 No. 29 | July 22, 1994

Download PDF Visit The Full Archive

Related Articles

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

May 23, 2003

Frist Backs Federal Funding For Stem Cell Research.

July 20, 2001

Medicare Program: HCFA Expands Coverage Of Cancer Screening Methods

January 9, 1998

In Brief: Jay Moskowitz Reassigned; Healy To Run For Ohio Republican Nomination To Senate

September 17, 1993

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003

Obey Questions NCI honesty, Transfers IARC Monograph Support To NIH

October 15, 1982